Latest News
Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics Inc Estimates – LSE:0JDK
- Return on equity % of Iovance Biotherapeutics Inc – XETR:2LB
- Iovance Biotherapeutics Reports Inducement Grants
- Iovance Biotherapeutics updates corporate presentation, affirms $410M–$420M 2026 revenue guidance
- Iovance Biotherapeutics Stock Pauses After Hitting New 52-Week High: What's Going On?
- Iovance Stock Surges as Strong Melanoma Drug Demand Drives Growth
- Form 8K Iovance Biotherapeutics Inc For: 29 September By Investing.com
- Why is Iovance Biotherapeutics stock surging today?
- IOVA Stock Hits Over 2-Year Highs – Why Iovance Raised Its FY2026 Revenue Outlook
- Iovance rises as 2026 revenue outlook tops analyst consensus
- Iovance Biotherapeutics raises 2026 revenue for...
- Why Iovance Biotherapeutics Stock Was on Fire Today
Headlines from the last 30 days, linking to the original publishers. See all market news →